Development

Inna Miroshnyk is Senior Scientist in the Pharmaceutical Materials Research Group, Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki (Finland).

Sabiruddin Mirza is Senior Scientist in the Drug Delivery and Nanotechnology Group, Centre for Drug Research, Faculty of Pharmacy, University of Helsinki (Finland).Tel. +358 9 191 59 582 

Articles

How can crystal engineering and pharma sciences be combined to enhance the clinical performance of drugs?

Capturing The Advantages Of Co-Crystals

Company and People Notes: Valeant and Biovail to Merge; GPhA Names Interim Director; And More.

Week of June 21, 2010: Company and People Notes: Valeant and Biovail to Merge; GPhA Names Interim Director; And More.

GSK Acquires Laboratorios Phoenix; Catalent Makes Executive Appointments; And More.

Week of June 14, 2010: Company and People Notes: GSK Acquires Laboratorios Phoenix; Catalent Makes Executive Appointments; And More.

Thermo Fisher to Acquire Fermentas; Pfizer Names Head of R&D; And More.

Week of May 31, 2010: Company and People Notes: Thermo Fisher to Acquire Fermentas; Pfizer Names Head of R&D; And More.

Sean Milmo is a freelance writer based in Essex, UK.

Europe moves to place excipient GMP and GDP standards on the same level as active pharmaceutical ingredients.

Report from Europe

Too much or too little control can actually lead to the same result.

Everybody's Got Problems

Bayer to Open San Francisco Innovation Hub; Lonza Bioscience Names COO; And More.

Week of May 24, 2010: Company and People Notes: Bayer to Open San Francisco Innovation Hub; Lonza Bioscience Names COO; And More.

Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.

Week of May 17, 2010: Company and People Notes: Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) published its "Ten Principles on Counterfeit Medicines" last week to draw public attention to the issue.

IFPMA launches Ten Principles on Counterfeit Medicines

Angie Drakulich was editorial director of Pharmaceutical Technology.

Effective May 1, 2010, the US Pharmacopeia has revised its Pending Monographs Guideline to clarify that excipients are eligible for pending-monograph status and can ultimately be included in an official National Formulary (NF) monograph.

Ingredients